ERBB2 and triple-negative breast carcinoma: In both cohorts, the median total lymphocyte count is highest in triple-negative breast cancer (TNBC), followed by the HER2-positive subtype, and lowest in the ER-positive/HER2-negative subtype (Fig. 1B).